Clinical Trials Logo

Clinical Trial Summary

Body dysmorphic disorder (BDD) is associated with high risk for suicide attempts (22-28%) and substance use disorders (49%), underscoring the importance of accurate, real-time risk detection in BDD. This study aims to use smartphone-based digital phenotyping to develop and validate unobtrusive, time-sensitive, and ecologically valid measures of key risk factors for suicide and substance misuse in BDD: negative affect states. As next steps, this research can be extended to detect risk transdiagnostically, with the goal of enabling just-in-time interventions to target suicide and substance misuse across psychiatric illnesses.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04254575
Study type Observational
Source Massachusetts General Hospital
Contact
Status Completed
Phase
Start date July 15, 2020
Completion date April 28, 2023

See also
  Status Clinical Trial Phase
Completed NCT02524301 - Evaluation of Brain Opioid Receptor Activity in Anorexia Nervosa : a PET [11C]Diprenorphine Study N/A
Completed NCT05078320 - Internet-delivered Cognitive-behaviour Therapy for Adolescents With Body Dysmorphic Disorder N/A
Recruiting NCT03918577 - Caloric Vestibular Stimulation for Modulation of Insight in Obsessive-Compulsive Spectrum Disorders N/A
Completed NCT01398904 - Attentional Bias in Body Dysmorphic Disorder N/A
Completed NCT03773549 - A Virtual Reality Study of Cognitive Biases in Body Dysmorphic Disorder
Recruiting NCT05607121 - TMS Visual Modulation in Body Dysmorphic Disorder N/A
Completed NCT03221738 - Smartphone-Administered App Treatment for Adults With Body Dysmorphic Disorder N/A
Completed NCT04103606 - A Mobile-App Training to Reduce Body Image Disorder Symptoms and Associated Features in Female University Students N/A
Recruiting NCT01093950 - White Light Scanning to Aid Body Contouring: A Pilot Project N/A
Recruiting NCT04899687 - Study of Dextromethorphan in OCD and Related Disorders Phase 2
Recruiting NCT05612425 - Text Message Safety Behavior Fading for Appearance Concerns N/A
Completed NCT06370559 - Relationship Between Repetitive Negative Thinking and CBT Outcomes
Completed NCT04656301 - Safety and Efficacy of Psilocybin for Body Dysmorphic Disorder Phase 2
Recruiting NCT06262412 - Internet-delivered Cognitive-behaviour Therapy for Child and Adolescent Body Dysmorphic Disorder N/A
Active, not recruiting NCT04034693 - Waitlist-Control Trial of Smartphone CBT for Body Dysmorphic Disorder (BDD) N/A
Recruiting NCT06346301 - Imagery Rescripting as a Stand-alone Treatment for OCD and BDD. N/A
Recruiting NCT01316627 - Study of Patients With Body Image Issues Treated With 2 Different Behavioral Interventions Phase 2
Completed NCT03517384 - Feasibility Pilot Study of Internet-based Cognitive Behavioral Therapy (CBT) for Body Dysmorphic Disorder With Global Recruitment N/A